Preference between serum homocysteine and urinary periostin as early predictive biomarkers of renal dysfunction among uncontrolled diabetics
Author:
Taha Mona Mohamed1, Mahdy-Abdallah Heba1, Shahy Eman Mohamed1, Mansour Nevine Abd El-Maksoud2, Fouad Marwa Mohamed2, Helmy Mona Adel1
Affiliation:
1. Environmental and Occupational Medicine Department , National Research Centre , Giza , Egypt 2. Occupational and Environmental Medicine Department , Faculty of Medicine, Cairo University , Cairo , Egypt
Abstract
Abstract
Objectives
Type 2 diabetes mellitus (T2DM) represents a serious public health problem. Environmental toxins, other than infectious agents or exposures can stimulate immune responses which are associated with the occurrence of T2DM. Diabetic nephropathy (DN) is a serious complication of diabetes that leads to changes in the structure and function of the kidneys. The study aimed to detect diagnostic biomarkers for (DN), at an early stage, to prevent disease progression in these patients and improve their outcomes.
Methods
This study was performed on 102 T2DM patients and 80 normal controls. Blood glucose, HbA1c, serum homocysteine (Hcy) and urinary periostin were assessed. Patients were divided into: controlled (n=46) (HbA1c <6.5%) and uncontrolled diabetics (n=56) (HbA1c >6.5%).
Results
The study results revealed a significant rise in blood glucose and HbA1c as well as serum Hcy levels in diabetic groups compared to controls. Also, urinary periostin exhibited significant elevation in diabetic groups. Serum glucose, HbA1c and serum Hcy revealed a highly significant difference between diabetic subgroups and control groups, while urinary periostin demonstrated a non-significant difference. Only, urinary periostin showed a significant increase in uncontrolled diabetics.
Conclusions
The highest levels of serum Hcy and urinary periostin were recorded only in the uncontrolled diabetics. Urinary periostin was demonstrated as a more preferable biomarker being a non-invasive sample for predicting renal insult in diabetic subjects. This biomarker could be performed regularly for early detection of DN. Also, it could be added to the periodic medical examinations of workers occupationally exposed to workplace pollutants inducing diabetes.
Funder
National Research Centre
Publisher
Walter de Gruyter GmbH
Subject
Complementary and alternative medicine
Reference31 articles.
1. Rehman, T, Shabbir, MA, Inam‐Ur‐Raheem, M, Manzoor, MF, Ahmad, N, Liu, Z-W, et al.. Cysteine and homocysteine as biomarker of various diseases. Food Sci Nutr 2020;8:4696–707. https://doi.org/10.1002/fsn3.1818. 2. Ye, B, Zhu, X, Zeng, Z, Ji, X, Ji, M. Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients. Pteridines 2021;32:11–6. https://doi.org/10.1515/pteridines-2020-0025. 3. Li, H, Lu, W, Wang, A, Jiang, H, Lyu, J. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from global burden of disease 2017. J Diabetes Invest 2021;12:346–56. https://doi.org/10.1111/jdi.13355. 4. Bréchon, F, Czernichow, P, Leroy, M, Blum-Boisgard, C. Chronic diseases in self- employed French workers. J Occup Environ Med 2005;909:15–47. https://doi.org/10.1097/01.jom.0000169566.45853.79. 5. Jiaa, YY, Yub, Y, Lia, HJ. The research status and prospect of Periostin in chronic kidney disease. Ren Fail 2020;42:1166–72. https://doi.org/10.1080/0886022x.2020.1846562.
|
|